Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.

Katragadda L, Shahid Z, Restrepo A, Muzaffar J, Alapat D, Anaissie E. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease. Transpl Infect Dis. 2013 Aug; 15(4):354-60.

View in: PubMed

subject areas

Aged
Antineoplastic Agents
Female
Humans
Immunoglobulins, Intravenous
Male
Middle Aged
Multiple Myeloma
Pancytopenia
Parvoviridae Infections
Parvovirus B19, Human
Stem Cell Transplantation
Treatment Outcome

authors with profiles

Daisy Alapat